126 related articles for article (PubMed ID: 31945379)
1. The Development and Validation of Prostate Cancer-specific Physician-Hospital Networks.
Jacobs BL; Yabes JG; Lopa SH; Heron DE; Chang CH; Bekelman JE; Nelson JB; Bynum JPW; Barnato AE; Kahn JM
Urology; 2020 Apr; 138():37-44. PubMed ID: 31945379
[TBL] [Abstract][Full Text] [Related]
2. Physician social networks and variation in prostate cancer treatment in three cities.
Pollack CE; Weissman G; Bekelman J; Liao K; Armstrong K
Health Serv Res; 2012 Feb; 47(1 Pt 2):380-403. PubMed ID: 22092259
[TBL] [Abstract][Full Text] [Related]
3. The Influence of Stereotactic Body Radiation Therapy Adoption on Prostate Cancer Treatment Patterns.
Jacobs BL; Yabes JG; Lopa SH; Heron DE; Chang CH; Bekelman JE; Nelson JB; Bynum JPW; Barnato AE; Kahn JM
J Urol; 2020 Jan; 203(1):128-136. PubMed ID: 31361571
[TBL] [Abstract][Full Text] [Related]
4. Population-Based Assessment of Determining Treatments for Prostate Cancer.
Chamie K; Williams SB; Hu JC
JAMA Oncol; 2015 Apr; 1(1):60-7. PubMed ID: 26182305
[TBL] [Abstract][Full Text] [Related]
5. Variation in use of active surveillance among men undergoing expectant treatment for early stage prostate cancer.
Filson CP; Schroeck FR; Ye Z; Wei JT; Hollenbeck BK; Miller DC
J Urol; 2014 Jul; 192(1):75-80. PubMed ID: 24518783
[TBL] [Abstract][Full Text] [Related]
6. Urologist-Level Correlation in the Use of Observation for Low- and High-Risk Prostate Cancer.
Tyson MD; Graves AJ; O'Neil B; Barocas DA; Chang SS; Penson DF; Resnick MJ
JAMA Surg; 2017 Jan; 152(1):27-34. PubMed ID: 27653425
[TBL] [Abstract][Full Text] [Related]
7. Physician variation in management of low-risk prostate cancer: a population-based cohort study.
Hoffman KE; Niu J; Shen Y; Jiang J; Davis JW; Kim J; Kuban DA; Perkins GH; Shah JB; Smith GL; Volk RJ; Buchholz TA; Giordano SH; Smith BD
JAMA Intern Med; 2014 Sep; 174(9):1450-9. PubMed ID: 25023650
[TBL] [Abstract][Full Text] [Related]
8. Influence of Geography on Prostate Cancer Treatment.
Tang C; Lei X; Smith GL; Pan HY; Hoffman KE; Kumar R; Chapin BF; Shih YT; Frank SJ; Smith BD
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1286-1295. PubMed ID: 33316361
[TBL] [Abstract][Full Text] [Related]
9. Locally advanced prostate cancer: a population-based study of treatment patterns.
Lowrance WT; Elkin EB; Yee DS; Feifer A; Ehdaie B; Jacks LM; Atoria CL; Zelefsky MJ; Scher HI; Scardino PT; Eastham JA
BJU Int; 2012 May; 109(9):1309-14. PubMed ID: 22085255
[TBL] [Abstract][Full Text] [Related]
10. Utilization of Active Surveillance and Watchful Waiting for localized prostate cancer in the daily practice.
Herden J; Weissbach L
World J Urol; 2018 Mar; 36(3):383-391. PubMed ID: 29330583
[TBL] [Abstract][Full Text] [Related]
11. Increasing Rate of Noninterventional Treatment Management in Localized Prostate Cancer Candidates for Active Surveillance: A North American Population-Based Study.
Bandini M; Nazzani S; Marchioni M; Preisser F; Tian Z; Moschini M; Abdollah F; Suardi N; Graefen M; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Clin Genitourin Cancer; 2019 Feb; 17(1):72-78.e4. PubMed ID: 30342845
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1).
Schymura MJ; Kahn AR; German RR; Hsieh MC; Cress RD; Finch JL; Fulton JP; Shen T; Stuckart E
BMC Cancer; 2010 Apr; 10():152. PubMed ID: 20403178
[TBL] [Abstract][Full Text] [Related]
13. Variation in the use of active surveillance for low-risk prostate cancer.
Löppenberg B; Friedlander DF; Krasnova A; Tam A; Leow JJ; Nguyen PL; Barry H; Lipsitz SR; Menon M; Abdollah F; Sammon JD; Sun M; Choueiri TK; Kibel AS; Trinh QD
Cancer; 2018 Jan; 124(1):55-64. PubMed ID: 28902401
[TBL] [Abstract][Full Text] [Related]
14. Expectant management of veterans with early-stage prostate cancer.
Filson CP; Shelton JB; Tan HJ; Kwan L; Skolarus TA; Saigal CS; Litwin MS
Cancer; 2016 Feb; 122(4):626-33. PubMed ID: 26540451
[TBL] [Abstract][Full Text] [Related]
15. The primary therapy chosen for patients with localized prostate cancer between the university hospital and its affiliated hospitals in Nara Uro-Oncological Research Group registration.
Tanaka N; Fujimoto K; Hirayama A; Samma S; Momose H; Kaneko Y; Haramoto M; Hayashi Y; Nakagawa Y; Otani T; Watanabe S; Hirao Y
BMC Urol; 2011 Apr; 11():6. PubMed ID: 21524283
[TBL] [Abstract][Full Text] [Related]
16. Physician social networks and variation in rates of complications after radical prostatectomy.
Evan Pollack C; Wang H; Bekelman JE; Weissman G; Epstein AJ; Liao K; Dugoff EH; Armstrong K
Value Health; 2014 Jul; 17(5):611-8. PubMed ID: 25128055
[TBL] [Abstract][Full Text] [Related]
17. [Patterns of care of patients with localized prostate cancer in Germany: a health care study with focus on active surveillance].
Chun FK; Becker A; Kluth LA; Seiler D; Schnell D; Fisch M; Graefen M; Weissbach L
Urologe A; 2015 Jan; 54(1):6-13. PubMed ID: 25391440
[TBL] [Abstract][Full Text] [Related]
18. Physician-Driven Variation in Nonrecommended Services Among Older Adults Diagnosed With Cancer.
Lipitz-Snyderman A; Sima CS; Atoria CL; Elkin EB; Anderson C; Blinder V; Tsai CJ; Panageas KS; Bach PB
JAMA Intern Med; 2016 Oct; 176(10):1541-1548. PubMed ID: 27533635
[TBL] [Abstract][Full Text] [Related]
19. Patterns of prostate cancer treatment by clinical stage and age.
Meltzer D; Egleston B; Abdalla I
Am J Public Health; 2001 Jan; 91(1):126-8. PubMed ID: 11189804
[TBL] [Abstract][Full Text] [Related]
20. Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER-Medicare investigation.
Beebe-Dimmer JL; Ruterbusch JJ; Cooney KA; Bolton A; Schwartz K; Schwartz AG; Heath E
Cancer Med; 2019 Jun; 8(6):3325-3335. PubMed ID: 31094098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
